Advertisement Pharmaceutical Business review - Page 749 of 5280 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
July 8, 2026

Biocytogen and Whitehawk partner to develop ADCs

Biocytogen and Whitehawk Therapeutics are set to develop bispecific antibody-drug conjugates (BsADCs), as part of a global partnership.

Continue
Whitehawk Therapeutics will assess the antibodies in conjunction with its ADC linker-payload platform. Credit: Gorodenkoff / Shutterstock.com.
July 8, 2026

FDA grants rare paediatric designation to Vanda’s CMT2S therapy

CMT2S is a rare, inherited neurological condition that progressively causes motor function loss and muscle weakness. Credit: SkazovD / Shutterstock.com.
July 7, 2026

Vertex signs agreement to acquire Crinetics for $10bn

The transaction adds two main endocrinology assets to Vertex’s portfolio. Credit: JHVEPhoto / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. EC approves AbbVie’s Tepkinly combination for follicular lymphoma
  2. Novartis to acquire Myricx Bio in up to $1.5bn deal
  3. Besins Healthcare boosts drug delivery portfolio with UniD deal
  4. SK bioscience to lead Gates Foundation-funded ROTOR project
  5. European Commission approves Novartis’ Itvisma to treat SMA

PRESS RELEASES

SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
HPLC 2025 in Bruges: Sharing Advanced Modelling Methods
HPLC 2025 in Bruges: Sharing Advanced Modelling Methods
Dr Imre Molnár Met Professor Ugur Sahin in Berlin, Laureate of the German National Prize, Together With His Wife Professor Özlem Türeci
Dr Imre Molnár Met Professor Ugur Sahin in Berlin, Laureate of the German National Prize, Together With His Wife Professor Özlem Türeci
Dr Imre Molnár Honoured With Tswett-Nernst European Award
Dr Imre Molnár Honoured With Tswett-Nernst European Award

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography